认知障碍和痴呆的血管及非血管机制
Vascular and Nonvascular Mechanisms of Cognitive Impairment and Dementia.
作者信息
Kara Betul, Gordon Marcia N, Gifani Mahsa, Dorrance Anne M, Counts Scott E
机构信息
Department of Translational Neuroscience, Michigan State University, 400 Monroe Avenue Northwest, Grand Rapids, MI 49503, USA.
Department of Pharmacology and Toxicology, Michigan State University, 1355 Bogue Street, East Lansing, MI 48824, USA.
出版信息
Clin Geriatr Med. 2023 Feb;39(1):109-122. doi: 10.1016/j.cger.2022.07.006. Epub 2022 Oct 18.
Abstract
Aging, familial gene mutations, and genetic, environmental, and modifiable lifestyle risk factors predispose individuals to cognitive impairment or dementia by influencing the efficacy of multiple, often interdependent cellular and molecular homeostatic pathways mediating neuronal, glial, and vascular integrity and, ultimately, cognitive status. This review summarizes data from foundational and recent breakthrough studies to highlight common and differential vascular and nonvascular pathogenic mechanisms underlying the progression of Alzheimer disease, vascular dementia, frontotemporal dementia, and dementia with Lewy bodies.
摘要
衰老、家族基因突变以及遗传、环境和可改变的生活方式风险因素，通过影响多种通常相互依存的细胞和分子稳态途径的功效，使个体易患认知障碍或痴呆症，这些途径介导神经元、胶质细胞和血管的完整性，最终影响认知状态。本综述总结了基础研究和近期突破性研究的数据，以突出阿尔茨海默病、血管性痴呆、额颞叶痴呆和路易体痴呆进展过程中常见和不同的血管及非血管致病机制。
相似文献
1
Vascular and Nonvascular Mechanisms of Cognitive Impairment and Dementia.
Clin Geriatr Med. 2023 Feb;39(1):109-122. doi: 10.1016/j.cger.2022.07.006. Epub 2022 Oct 18.
2
The Role of Vascular Risk Factors in Cognitive Impairment and Dementia and Prospects for Prevention.
Clin Geriatr Med. 2023 Feb;39(1):123-134. doi: 10.1016/j.cger.2022.07.007. Epub 2022 Oct 18.
3
Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease.
Mt Sinai J Med. 2012 Nov-Dec;79(6):664-73. doi: 10.1002/msj.21347.
4
Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.
Biochim Biophys Acta. 2016 May;1862(5):975-82. doi: 10.1016/j.bbadis.2015.12.009. Epub 2015 Dec 17.
5
Orthostatic Hypotension: An Important Risk Factor for Clinical Progression to Mild Cognitive Impairment or Dementia. The Amsterdam Dementia Cohort.
J Alzheimers Dis. 2019;71(1):317-325. doi: 10.3233/JAD-190402.
6
Hypertension-induced cognitive impairment: from pathophysiology to public health.
Nat Rev Nephrol. 2021 Oct;17(10):639-654. doi: 10.1038/s41581-021-00430-6. Epub 2021 Jun 14.
7
A selenium species in cerebrospinal fluid predicts conversion to Alzheimer's dementia in persons with mild cognitive impairment.
Alzheimers Res Ther. 2017 Dec 19;9(1):100. doi: 10.1186/s13195-017-0323-1.
8
[Vascular cognitive impairment].
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(10):17-23. doi: 10.17116/jnevro202212210117.
9
Pathological Continuum From the Rise in Pulse Pressure to Impaired Neurovascular Coupling and Cognitive Decline.
Am J Hypertens. 2020 Apr 29;33(5):375-390. doi: 10.1093/ajh/hpaa001.
10
Molecular biomarkers for vascular cognitive impairment and dementia.
Nat Rev Neurol. 2023 Dec;19(12):737-753. doi: 10.1038/s41582-023-00884-1. Epub 2023 Nov 13.
引用本文的文献
1
Development and multi-center validation of a high-performance predictive model for early detection of cognitive impairment in older adults: data-based on communities in Northern China.
Neurol Sci. 2025 Jun 14. doi: 10.1007/s10072-025-08293-6.
2
A Longitudinal Study of the Relationship Among Cognition, Mood Symptoms, and Markers of Brain Health in Older Age Bipolar Disorder: Une étude longitudinale de la relation entre la cognition, les symptômes thymiques, et les marqueurs de la santé du cerveau en présence de troubles bipolaires du sujet âgé.
Can J Psychiatry. 2025 May 25:7067437251343295. doi: 10.1177/07067437251343295.
3
Analysis of the Prevalence of Mild Cognitive Impairment and its Influencing Factors in the Elderly Population in Huzhou City.
Actas Esp Psiquiatr. 2025 May;53(3):526-534. doi: 10.62641/aep.v53i3.1722.
4
Effects of repetitive transcranial magnetic stimulation on learning and memory cognitive function in rats with vascular cognitive impairment and its neural induction mechanism.
BMC Neurosci. 2025 Mar 18;26(1):24. doi: 10.1186/s12868-025-00933-z.
5
Diagnosis and Management of Dementia for the Nephrology Clinician: A Review.
Am J Kidney Dis. 2025 Jul;86(1):97-108. doi: 10.1053/j.ajkd.2025.01.007. Epub 2025 Mar 3.
6
A systematic review and meta-analysis of pteridines in mild cognitive impairment and Alzheimer's disease.
BMC Geriatr. 2025 Feb 13;25(1):94. doi: 10.1186/s12877-025-05760-9.
7
The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysis.
Semin Arthritis Rheum. 2024 Dec;69:152570. doi: 10.1016/j.semarthrit.2024.152570. Epub 2024 Oct 11.
8
Innovation at the Intersection: Emerging Translational Research in Neurology and Psychiatry.
Cells. 2024 May 7;13(10):790. doi: 10.3390/cells13100790.
9
Potential Intersections between lncRNA, Vascular Cognitive Impairment, and Immunization Strategies: Insights and Future Directions.
Vaccines (Basel). 2024 Feb 28;12(3):251. doi: 10.3390/vaccines12030251.
10
COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.
Cells. 2023 Nov 10;12(22):2601. doi: 10.3390/cells12222601.
本文引用的文献
1
Glial cells in Alzheimer's disease: From neuropathological changes to therapeutic implications.
Ageing Res Rev. 2022 Jun;78:101622. doi: 10.1016/j.arr.2022.101622. Epub 2022 Apr 12.
2
Post-Stroke Cognitive Impairment and Dementia.
Circ Res. 2022 Apr 15;130(8):1252-1271. doi: 10.1161/CIRCRESAHA.122.319951. Epub 2022 Apr 14.
3
New insights into the genetic etiology of Alzheimer's disease and related dementias.
Nat Genet. 2022 Apr;54(4):412-436. doi: 10.1038/s41588-022-01024-z. Epub 2022 Apr 4.
4
Inflammation in dementia with Lewy bodies.
Neurobiol Dis. 2022 Jun 15;168:105698. doi: 10.1016/j.nbd.2022.105698. Epub 2022 Mar 18.
5
Complement C3a Receptor (C3aR) Mediates Vascular Dysfunction, Hippocampal Pathology, and Cognitive Impairment in a Mouse Model of VCID.
Transl Stroke Res. 2022 Oct;13(5):816-829. doi: 10.1007/s12975-022-00993-x. Epub 2022 Mar 8.
6
Gut Microbiota Composition Is Related to AD Pathology.
Front Immunol. 2022 Jan 31;12:794519. doi: 10.3389/fimmu.2021.794519. eCollection 2021.
7
TDP-43 pathology: From noxious assembly to therapeutic removal.
Prog Neurobiol. 2022 Apr;211:102229. doi: 10.1016/j.pneurobio.2022.102229. Epub 2022 Jan 29.
8
Co-expression network analysis of frontal cortex during the progression of Alzheimer's disease.
Cereb Cortex. 2022 Nov 9;32(22):5108-5120. doi: 10.1093/cercor/bhac001.
9
Vascular Dementia and Crosstalk Between the Complement and Coagulation Systems.
Front Cardiovasc Med. 2021 Dec 23;8:803169. doi: 10.3389/fcvm.2021.803169. eCollection 2021.
10
TDP-43 Pathology in Alzheimer's Disease.
Mol Neurodegener. 2021 Dec 20;16(1):84. doi: 10.1186/s13024-021-00503-x.
Zotero 插件